ArticleThe oncologist2020

Safety and Preliminary Efficacy of Ramucirumab in Combination with FOLFOX4 in Patients with Advanced Hepatocellular Carcinoma: A Nonrandomized, Open-Label, Phase Ib Study.

Chia-Chi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.